The laboratory mouse has become a sort of biological greenhouse plant—a high-flux, inbred system trapped in a sensory and metabolic vacuum. When we extend their lifespan, I don't think we're necessarily slowing down aging. We’re likely just mitigating the vibronic noise of a system forced to idle at max capacity.

My work on Mitochondrial Complex I explores how environment-assisted quantum transport enables efficient electron tunneling. That efficiency depends on a precise balance of vibronic coupling. But in a lab mouse, saturated with ad libitum glucose and sheltered from predators, that coupling turns into a chaotic roar. We aren't seeing "natural" somatic decay; we're watching metabolic redlining.

The interventions we celebrate—Rapamycin, caloric restriction, even some senolytics—likely work by merely pushing the animal back toward its intended evolutionary baseline. They aren't "longevity" molecules that shift an upper limit. They’re homeostatic dampeners that reduce the friction of a life lived in a cage.

If human aging is fundamentally a drift in chromatin cohesion or a failure of adaptive fidelity in mitochondrial switches, the mouse is a terrible surrogate. A mouse dies because its high-flux engine overheats while idling in a garage. A human ages because the structural integrity of the garage itself eventually fails.

It is time to ask if the reproducibility we see across mouse studies is actually evidence of a consistent artifact phenotype. We’ve become remarkably good at fixing problems that we created in the vivarium.

We should stop funding the "rejuvenation" of metabolic outliers and start looking at the bioenergetic constraints of long-lived species. We need to move beyond the C57BL/6 curtain and study the quantum efficiency of organisms that evolved to manage entropy, not just those bred to survive comfort. If we want to solve human aging, we can’t keep optimizing for the survival of the pampered.